Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol versus fentanyl for analgesia in mechanically ventilated critically ill adults
ChiCTR1900028202Phase 4Not yet recruiting
- Sponsor
- Hebei General Hospital
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butorphanol, fentanyl and propofol in pain and critical illness (2 arms), sponsored by Hebei General Hospital. Primary endpoints: Analgesic score, Sedative score and 3 more. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
butorphanolfentanylpropofol
03
Conditions
paincritical illness
Beyond the preview
Go deeper on ChiCTR1900028202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028202.